NEXGENIA, INC.
Stimuli-responsive magnetic nanoparticles for T cell isolation and activation in CAR-T cell manufacturing
- Sector
- Biotech
- Headquarters
- SEATTLE, WA
- Founded
- 2011
- Latest Form D
- $119K, May 2018
- Total capital
- $4.3M
- Federal grants
- $232K
- 1 award · 2016
- Rank in peer group#14 of 20
- Private capital raised
- $4.1M
- 5 Form D · last May 2018
- 101 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$119K
- Offering registeredForm D · SEC · 4th filing$2K
- Private capital raisedForm D · SEC · 3rd filing$1.9M
- Federal grantHealth and Human S · Phase I · Stimuli-responsive reagents for improved cell isolations and activations$232K
- Private capital raisedForm D · SEC · 2nd filing$1.6M
- Private capital raisedForm D · SEC · 1st filing$500K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 20 peers
Line = medianBiotech · Material
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Charles P. WaiteDirectorNamed in SEC Form D filings
- David UrdalDirectorNamed in SEC Form D filings
- Martin SimonettiDirectorNamed in SEC Form D filings
- Ron MyersExecutive Officer, DirectorNamed in SEC Form D filings
- Steven GillisDirectorNamed in SEC Form D filings
- Stewart ParkerDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 4- PendingCell-surface Molecule Binding Stimuli-responsive Polymer Compositions And MethodsUSPTOApplication 16084546
- PendingStimuli-responsive Magnetic NanoparticlesUSPTOApplication 14893926
- PendingCell-surface Molecule Binding Stimuli-responsive Polymer Compositions And Methods Cross-reference To Related ApplicationsUSPTOApplication PCTUS2017022594
Show all 4 patent records
- Cell-surface Molecule Binding Stimuli-responsive Polymer Compositions And MethodsMar 14, 2019 · Application 16084546Pending
- Stimuli-responsive Magnetic NanoparticlesApr 28, 2016 · Application 14893926Pending
- Cell-surface Molecule Binding Stimuli-responsive Polymer Compositions And Methods Cross-reference To Related ApplicationsApplication PCTUS2017022594Pending
- Cell-surface Molecule Binding Stimuli-responsive Polymer Compositions And MethodsApplication 62308672Pending
Related companies, and why
- Deciduous TherapeuticsSimilar federal contract value in Biotech · null in contracts
- AdimabSimilar federal contract value in Biotech · null in contracts
- AvitideSimilar federal contract value in Biotech · null in contracts
- Terremoto BiosciencesSimilar federal contract value in Biotech · null in contracts
- NephroDI Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Cerebral TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .